secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-02-01T23:59:59+00:00
Accession:  0001493152-24-004619
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics raises $1M via convertible note with Ingodwe Trust
-------------------------------------------------------------------------

- Issued 12% simple interest one-year convertible promissory note for $1,000,000 principal.
- Conversion at 10% discount to 10-day VWAP; optional warrant for 50% of conversion shares at 120% of conversion price.
- Proceeds used for working capital; mandatory conversion if public offering occurs before maturity.
- Lender Ingodwe Trust is an accredited investor; securities issued under Rule 506(b) exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224004619/0001493152-24-004619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224004619/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-004619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer